Evidence map›Paper›PMID 14657501›Full record

ArticleScience (New York, N.Y.)2003

Regulation of cell polarity and protrusion formation by targeting RhoA for degradation.

Hong-Rui Wang, Yue Zhang, Barish Ozdamar, Abiodun A Ogunjimi, Evguenia Alexandrova, Gerald H Thomsen, Jeffrey L Wrana

Abstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 291 papers.

0numbers the graph read from it
0cells of the map it votes in
291citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

291 citing papers in PubMed, 554 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The CaPediatric nephrology (Berlin, Germany) · 2025
    Review
  9. Research and development prospects of TRIM65.Journal of cancer research and clinical oncology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

231 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hong-Rui WangProgram in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M56 1x5, Canada.
Yue Zhang
Barish Ozdamar
Abiodun A Ogunjimi
Evguenia Alexandrova
Gerald H Thomsen
Jeffrey L Wrana
University of Toronto · CA

Funding

Smurf Ubiquitin Ligases in Xenopus DevelopmentR01HD032429 · NICHD · STATE UNIVERSITY NEW YORK STONY BROOK · PI THOMSEN, GERALD H · 1997 to 2005
$1.9M
NICHD NIH HHS HD32429NICHD NIH HHS R01 HD032429
6 · The paper itself

Abstract

The Rho family of small guanosine triphosphatases regulates actin cytoskeleton dynamics that underlie cellular functions such as cell shape changes, migration, and polarity. We found that Smurf1, a HECT domain E3 ubiquitin ligase, regulated cell polarity and protrusive activity and was required to maintain the transformed morphology and motility of a tumor cell. Atypical protein kinase C zeta (PKCzeta), an effector of the Cdc42/Rac1-PAR6 polarity complex, recruited Smurf1 to cellular protrusions, where it controlled the local level of RhoA. Smurf1 thus links the polarity complex to degradation of RhoA in lamellipodia and filopodia to prevent RhoA signaling during dynamic membrane movements.

Indexed as

Cell MovementCell PolarityAnimalscdc42 GTP-Binding ProteinCell LineCell Line, TumorCell MembraneCell SizeCell Transformation, NeoplasticCytoskeletonGuanine Nucleotide Exchange FactorsHumansIntercellular JunctionsMiceNIH 3T3 CellsProtein Kinase Ccdc42 GTP-Binding ProteinGuanine Nucleotide Exchange FactorsProtein Kinase CProtein Kinase C zetarhoA GTP-Binding ProteinRNA, Small InterferingSmurf1 protein, mouseSMURF2 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID14657501
OpenAlexW2063090066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.